Advanced fill and finish services

We provide advanced fill and finish services within controlled environments, maintaining sterility and product integrity across vials, syringes, and other final containers to meet the highest quality and regulatory standards

amatsigroup-idron-isolateur

Aseptic manufacturing facility

Our sterile fill and finish activities are in full compliance with Annex 1 standards. With 2 autonomous production areas tailored for lyophilized and liquid products, we are equipped to handle up to 5000 vials and 6000 vials or syringes respectively.

Last enhancement includes new equipment installations such as a boiler, steam generator, autoclave (allowing terminal sterilization for small batches) and an advanced environmental monitoring system. The lyophilizer and depyrogenation oven have been revamped, ensuring top-notch quality and performance.

adobestock_417175689

Parenteral formulation and sterile manufacturing

Our optimised aseptic processes and expertise in parenteral formulation and sterile manufacturing set us apart. Our advanced production lines are designed for both liquid and lyophilised forms (Lyophilisation), catering to various fill volumes and minimising dead volume. We employ disposable product contact parts and materials to expedite the development process.

With batch sizes ranging from less than 0.5L to 50L and various options for vials, prefilled syringes, and more, we are equipped to meet your unique manufacturing needs.

Our capabilities

We provide a comprehensive range of aseptic processing services tailored to diverse drug product formats. Our capabilities support a wide variety of compounds, primary packaging types, batch sizes, and fill volumes—making us the ideal partner for converting APIs or bulk materials into finished dosage forms for both clinical and commercial use.

 

Our expertise in sterile aseptic filling covers small molecules and biologics, including peptides, proteins, monoclonal antibodies, and more, with batch sizes of up to 5,000 units and expansion to 86,000 units by April 2026. 

adobestock_528567825-1

Let's advance your innovation together